Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure
Primary Purpose
Primary Open Angle Glaucoma, Pseudoexfoliative Glaucoma
Status
Terminated
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Phacoemulsification, implantation of intraocular lens
Phacoemulsification, Implantation of IOL, trabeculotomy
Sponsored by
About this trial
This is an interventional treatment trial for Primary Open Angle Glaucoma focused on measuring glaucoma, cataract, surgery, intraocular pressure, phacoemulsification, trabeculotomy
Eligibility Criteria
Inclusion Criteria: Clinical Diagnosis of Primary Open Angle or Pseudoexfoliative Glaucoma and Cataract Exclusion Criteria: Other glaucoma than POAG or PEX-Glaucoma Medically uncontrolled Glaucoma: IOP > 24 mmHg with two topical medications IOP > 21 mmHg with three topical medications IOP < 18 mmHg with two topical medications IOP < 16 mmHg with three topical medications previous ocular surgery other ocular pathologies affecting visual acuity disorders of immune system
Sites / Locations
Outcomes
Primary Outcome Measures
Number of Patients with Constant Intraocular Pressure <18 mmHg with/without medication
Secondary Outcome Measures
Number of Patients with Constant Intraocular Pressure <18 mmHg without medication
Number of Patients with Constant Intraocular Pressure <21 mmHg with/without medication
Number of Patients needing surgical retreatment
Number of Patients with failure of surgical retreatment
Mean IOP after 1 and 2 years
Mean number of medication after 1 and 2 years
Number of intraoperative complications
comparison of postoperative complications between the groups
Visual acuity
decrease in perimetry
Full Information
NCT ID
NCT00346931
First Posted
June 29, 2006
Last Updated
July 22, 2010
Sponsor
Medical University of Vienna
1. Study Identification
Unique Protocol Identification Number
NCT00346931
Brief Title
Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure
Official Title
Phacotrabeculotomy vs. CCI+Phaco in Patients With Borderline Control of Intraocular Pressure
Study Type
Interventional
2. Study Status
Record Verification Date
June 2006
Overall Recruitment Status
Terminated
Study Start Date
December 2004 (undefined)
Primary Completion Date
June 2007 (Actual)
Study Completion Date
June 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Medical University of Vienna
4. Oversight
5. Study Description
Brief Summary
The purpose of the study is to determine whether combined cataract and glaucoma surgery (phacotrabeculotomy)is more effective in lowering intraocular pressure than cataract surgery alone in patients with borderline control of intraocular pressure.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Open Angle Glaucoma, Pseudoexfoliative Glaucoma
Keywords
glaucoma, cataract, surgery, intraocular pressure, phacoemulsification, trabeculotomy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
9 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Phacoemulsification, implantation of intraocular lens
Intervention Type
Procedure
Intervention Name(s)
Phacoemulsification, Implantation of IOL, trabeculotomy
Primary Outcome Measure Information:
Title
Number of Patients with Constant Intraocular Pressure <18 mmHg with/without medication
Secondary Outcome Measure Information:
Title
Number of Patients with Constant Intraocular Pressure <18 mmHg without medication
Title
Number of Patients with Constant Intraocular Pressure <21 mmHg with/without medication
Title
Number of Patients needing surgical retreatment
Title
Number of Patients with failure of surgical retreatment
Title
Mean IOP after 1 and 2 years
Title
Mean number of medication after 1 and 2 years
Title
Number of intraoperative complications
Title
comparison of postoperative complications between the groups
Title
Visual acuity
Title
decrease in perimetry
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical Diagnosis of Primary Open Angle or Pseudoexfoliative Glaucoma and Cataract
Exclusion Criteria:
Other glaucoma than POAG or PEX-Glaucoma
Medically uncontrolled Glaucoma:
IOP > 24 mmHg with two topical medications IOP > 21 mmHg with three topical medications
IOP < 18 mmHg with two topical medications IOP < 16 mmHg with three topical medications
previous ocular surgery
other ocular pathologies affecting visual acuity
disorders of immune system
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clemens Vass, Univ.Prof.Dr.med.univ.
Organizational Affiliation
Medical University of Vienna
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure
We'll reach out to this number within 24 hrs